Prevalence of advanced hepatic fibrosis and individualization of associated risk factors by Bayesian analysis in MASLD patients in French cardio-metabolic health networks.
The aim of this study was to determine the prevalence of advanced hepatic fibrosis and to individualize using Bayesian analysis its associated risk factors in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) being cared for in three Alsatian cardio-metabolic health netw...
Saved in:
| Main Authors: | Michel Doffoel, Frédéric Chaffraix, Archia Chahard, Dominique Gras, Odile Bonomi, Corinne Bildstein, Simona Tripon, Maude Royant, Nicolas Meyer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0316158 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Value of TyG-Related Indices in Evaluating MASLD and Significant Liver Fibrosis in MASLD
by: Haoxuan Zou, et al.
Published: (2025-01-01) -
Association of serum iron status with MASLD and liver fibrosis.
by: Wenying Guo, et al.
Published: (2025-01-01) -
Targeting duodenum to reverse MASLD
by: Amedeo Lonardo, et al.
Published: (2025-06-01) -
Long-term exposure to air pollution and liver fibrosis in the elderly with MASLD
by: Yanqi Lan, et al.
Published: (2025-08-01) -
Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD
by: Tianyuan Yang, et al.
Published: (2025-04-01)